Nomura Holdings, Inc. · NMR · FY2027 Q1 · Calendar Q3 2026

Nomura raises long-term targets after broad-based Q1 improvement

The current quarter supports a constructive view of Nomura's operating trajectory: growth was broad-based, recurring-revenue assets reached a record, and management raised its 2030 targets. The evidence is stronger for improving business momentum than for a low-risk earnings path, because wholesale seasonality, market exposure, and capital constraints remain material.

Reported Before market openNYSEFinancial Services $27.42B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.30 Consensus $0.23
EPS surprise +30.4% Reported versus consensus
Reported revenue $4.31B Consensus $3.49B
Revenue surprise +23.3% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move +0.6% Event window
SPY move -1.5% Same window
Abnormal move +2.2% Stock minus SPY
Volume 1.5× Versus trailing sessions
Subsequent drift +3.9% Up to 20 sessions
NMRSPY benchmark

Ask FN2 about NMR FY2027 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Compared with the prior analysis, the current quarter showed growth across all divisions, record overseas-region income, a new deposit-sweep service, and higher 2030 targets. The emphasis shifted from prior-quarter impairment and acquisition integration to recurring revenue, international wealth management, and equity-led momentum.

Guidance delta

Management raised its 2030 ROE and pretax-income targets, while noting a likely seasonal slowdown in wholesale revenue in the second half of the year.

Key takeaways

  • Revenue and pretax profit increased across all divisions, with ROE at its highest level since 2020.
  • Recurring-revenue assets reached an all-time high, supported by net inflows and cost coverage.
  • International operations and equity businesses were key growth drivers, while wholesale benefited from strong equity revenue.
  • The quarter added evidence of operating momentum, but seasonal and market-related variability remains important.

Management priorities

  • Scale the deposit-sweep service and deepen banking products.
  • Expand International Wealth Management in Asia and the Americas.
  • Continue focusing on equity and emerging-market equity funds as growth engines.
  • Execute structural reforms and the planned headquarters relocation with limited earnings disruption.

Follow NMR with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
NMR EPS earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q1 '25 actual $0.14, None Q2 '25 estimate $0.14 Q2 '25 actual $0.22, beat Q4 '25 actual $0.16, None Q1 '26 estimate $0.25 Q1 '26 actual $0.24, miss Q3 '26 estimate $0.24 Q3 '26 actual $0.18, miss Q4 '26 estimate $0.21 Q4 '26 actual $0.16, miss Q1 '27 estimate $0.23 Q1 '27 actual $0.30, beat Q2 '27 estimate $0.20 Q2 '27 actual $0.22, beat Q3 '27 estimate $35.21 Q4 '27 estimate $36.35 Q1 '28 estimate $36.53 Q2 '28 estimate $36.40
Show 2 more >

Analyst Consensus ?

ConsensusHold9 ratings
Bullish333.3%
Neutral666.7%
Bearish00.0%

Analyst 52W Price Targets

$9.38Current
$5.79Low
$8Average
$10.2High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 31, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
JP Morgan Overweight NeutralUpgradeMar 19, 2026
Jefferies Hold BuyDowngradeJan 25, 2023
Goldman Sachs Neutral BuyDowngradeMar 30, 2021
Credit Suisse Neutral OutperformDowngradeFeb 10, 2016
Deutsche Bank Hold BuyDowngradeFeb 8, 2016
UBS Neutral BuyDowngradeJul 22, 2015
Barclays Equal Weight UnderperformUpgradeJun 23, 2015
Morgan Stanley Overweight Equal WeightUpgradeMar 21, 2013
Macquarie Outperform NeutralUpgradeFeb 14, 2013
Show less

Named analyst price targets

Upside is calculated against the persisted current price $9.38. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
NomuraNatsumu Tsujino$10.2$8.61 +8.7%Jun 25, 2026
Bank of America SecuritiesNatsumu Tsujino$5.79$5.22 -38.3%Oct 22, 2024

Track every rating change on NMR the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Nomura Holdings, Inc. engages in the provision of investment, financing, and related services to individual, institutional, and government clients worldwide. It operates through three segments: Wealth Management, Investment Management, and Wholesale. The Wealth Management segment offers investment consultation services. The Investment Management segment provides investment management services and investment solutions, such as establishing and managing investment trusts, discretionary investment services, as well as investment and management for investment vehicles, and for funds for…

Historical context

All NMR earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the NMR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-07-29T18:04:47.387417+00:00
  2. FN2 earnings calendar · 2026-09-03T01:23:14.877038+00:00
  3. Polygon adjusted daily market bars · 2026-10-31T17:50:42.455434+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-31T17:50:42.452602+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-31. For educational purposes only; not investment advice.